Eosinophilic esophagitis, commonly called EoE, is a chronic immune-driven disease in which a specific type of white blood cell, eosinophils, builds up in the lining of the esophagus and causes inflammation, swelling, and eventually scarring. Once considered rare, EoE now affects more than 1 in 1,000 people in Western countries and is one of the leading causes of difficulty swallowing and food getting stuck in the throat.
What Happens Inside the Esophagus
EoE is fundamentally an allergic disease, though not in the way most people picture allergies. Rather than the immediate throat-swelling reaction of anaphylaxis, EoE is a slow-burning immune response. When certain foods or environmental allergens are encountered, the immune system sends signals through a cascade involving molecules like IL-13 and a chemical attractant called eotaxin-3 (CCL26), which pulls eosinophils into the esophageal tissue where they do not normally belong in significant numbers.1PubMed Central. Eosinophilic esophagitis: Immune mechanisms and therapeutic targets The process also involves alarm signals from the esophageal lining itself, along with activation of several immune cell types beyond eosinophils, including mast cells and specialized immune cells called ILC2s.2PubMed Central. The Immune Architecture of Eosinophilic Esophagitis: Mechanisms, Therapeutic Targets, and Precision Management
The eosinophils release toxic proteins that damage the esophageal lining. Over time, this ongoing inflammation triggers tissue remodeling: the surface layer thickens, a layer of scar tissue (fibrosis) forms beneath it, and the smooth muscle of the esophagus itself can enlarge. These structural changes cause the rings, narrowing, and fragile tissue that make EoE so troublesome in daily life.3PubMed Central. Tissue remodeling in eosinophilic esophagitis The esophagus essentially becomes stiff and narrow, losing the ability to move food along smoothly.
Symptoms Look Different at Different Ages
One reason EoE often goes unrecognized for years is that its symptoms change depending on the patient’s age. Infants and toddlers tend to refuse food, vomit frequently, and fall behind on growth milestones. Feeding difficulties can be so severe that children develop aversions to textures or entire categories of food, with real consequences for growth and development.4PubMed Central. Significance of feeding dysfunction in eosinophilic esophagitis Older children often report heartburn and abdominal pain alongside difficulty swallowing.5Current Pediatric Reviews. Eosinophilic Esophagitis in Children: Clinical Findings and Diagnostic Approach
In teenagers and adults, the picture shifts. The hallmark symptom becomes intermittent trouble swallowing solid foods, a sensation doctors call dysphagia. People frequently describe food “sticking” or “getting caught” partway down the chest. The classic scenario is a piece of meat or bread that simply will not go down, sometimes requiring an emergency room visit for endoscopic removal.6PubMed. Eosinophilic oesophagitis: a common cause of dysphagia in young adults? EoE is now recognized as a leading cause of these food impaction emergencies in both children and adults.7PubMed Central. Pathophysiology of Dysphagia in Eosinophilic Esophagitis: Causes, Consequences, and Management
Many adults develop quiet coping strategies long before they receive a diagnosis. They chew excessively, cut food into tiny pieces, drink water with every bite, or simply avoid foods they know will cause trouble. These behaviors become so routine that patients sometimes do not recognize them as symptoms at all, which contributes to the often-lengthy delay between symptom onset and diagnosis.
How EoE Is Diagnosed
There is no blood test or imaging scan that can confirm EoE on its own. Diagnosis requires an upper endoscopy, a procedure in which a thin camera is passed through the mouth into the esophagus. During the procedure, the doctor takes small tissue samples (biopsies) from the esophageal wall. Three criteria need to be met: the patient has symptoms related to esophageal trouble, the biopsies show at least 15 eosinophils per high-power microscope field, and other possible causes of esophageal eosinophilia have been ruled out.8PubMed Central. Eosinophilic esophagitis: diagnostic tests and criteria
That 15-eosinophil threshold is well validated. In one study evaluating the cutoff, it achieved perfect sensitivity and a specificity above 95 percent at the patient level, meaning it reliably catches true cases without flagging too many false positives.9Modern Pathology. Distribution and variability of esophageal eosinophilia in patients undergoing upper endoscopy Still, because eosinophils can cluster in patches rather than spreading evenly, doctors typically take biopsies from multiple spots along the esophagus to avoid missing the inflammation.
The role of proton pump inhibitors (PPIs, the acid-blocking drugs like omeprazole) in diagnosis has shifted over the years. Doctors used to require that patients fail a PPI trial before they could be diagnosed with EoE, because some patients with esophageal eosinophilia respond to PPIs alone. Updated guidelines now treat PPIs as a potential EoE therapy rather than a diagnostic gate, recognizing that PPI-responsive eosinophilia and EoE likely overlap rather than being separate conditions.10PubMed Central. Proton Pump Inhibitor Therapy for Eosinophilic Esophagitis: History, Mechanisms, Efficacy, and Future Directions
Treatment Through Diet
Because EoE is driven by allergens, one of the core treatment approaches is removing the foods that trigger the immune response. Several elimination diet strategies exist, and the evidence shows they genuinely work for a meaningful share of patients. A meta-analysis pooling over 1,700 patients across 34 studies found that dietary elimination achieved tissue-level remission in roughly half of all patients and improved symptoms in about four out of five.11PubMed. Efficacy of Elimination Diets in Eosinophilic Esophagitis: A Systematic Review and Meta-analysis
The most common approach is the six-food elimination diet, which removes milk, wheat, eggs, soy, fish/shellfish, and tree nuts/peanuts. A simpler version removes just one or two foods, most often milk, since cow’s milk is the single most common trigger. In a randomized trial comparing six-food elimination to removal of animal milk alone, both groups showed meaningful improvement, with about 40 percent achieving remission on the six-food diet and about a third on the one-food diet, a difference that was not statistically significant.12The Lancet Gastroenterology & Hepatology. Six-food versus one-food elimination diet in eosinophilic oesophagitis (SIX-FED) A four-food elimination diet in children produced remission in about two-thirds of patients, with significant improvements in symptoms and endoscopic findings.13PubMed Central. Efficacy of a 4-Food Elimination Diet for Children With Eosinophilic Esophagitis
The catch with dietary therapy is logistics, not effectiveness. After an elimination diet produces remission, foods are reintroduced one at a time with repeat endoscopies after each reintroduction to see which specific food triggers the inflammation. This process can take months and multiple procedures. And conventional allergy testing, the skin-prick tests and blood panels that work for other allergic conditions, does not reliably predict which foods trigger EoE. A comprehensive study using five different allergy testing methods found that none could accurately identify the actual food culprits.14PubMed. Allergy tests do not predict food triggers in adult patients with eosinophilic oesophagitis This is one of the more frustrating aspects of EoE management: you cannot simply get a test to tell you what to avoid.
Medications That Treat EoE
Swallowed topical corticosteroids are the most established drug treatment for EoE. Unlike inhaled steroids for asthma, these formulations are designed to coat the esophagus rather than reach the lungs. Patients either swallow fluticasone from a metered-dose inhaler (puffing it into the mouth then swallowing instead of inhaling) or take a specially formulated budesonide preparation. Esophagus-targeted formulations have shown response rates up to 85 percent, and in 2018 an orodispersible budesonide tablet became the first drug officially approved for EoE in Europe.15PubMed Central. Treatment of eosinophlic esophagitis with swallowed topical corticosteroids A head-to-head trial confirmed that both budesonide and fluticasone significantly reduced eosinophil counts and improved swallowing difficulty and endoscopic findings.16PubMed Central. Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial
The main limitation is what happens after you stop. EoE tends to return when treatment is discontinued, so many patients need ongoing low-dose maintenance therapy. Long-term data on topical steroids remain limited, and questions about the best maintenance dose and schedule are still being worked out.15PubMed Central. Treatment of eosinophlic esophagitis with swallowed topical corticosteroids Side effects are generally mild because these steroids act locally rather than systemically, though oral thrush (a yeast infection in the mouth) is a common annoyance.
PPIs also play a therapeutic role. Some patients respond to acid suppression alone, and PPIs appear to have anti-inflammatory properties beyond just reducing acid. They are often used as a first-line treatment or in combination with other approaches.
Biologic Therapy and Dupilumab
The arrival of dupilumab (brand name Dupixent) has been a significant development for EoE. Dupilumab is an injectable antibody that blocks two key inflammatory signals, IL-4 and IL-13, both central to the immune cascade driving EoE. It was already used for conditions like eczema and asthma before its EoE approval.
In the pivotal trial in adults and adolescents, about 60 percent of patients on weekly dupilumab achieved histologic remission at 24 weeks, compared to just 5 percent on placebo.17PubMed. Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis Those gains held up over the longer term. In the extension study, 85 percent of patients who continued weekly dupilumab for a full year reached the stricter threshold of 6 or fewer eosinophils per high-power field, with eosinophil counts dropping by roughly 96 percent from baseline.18The Lancet Gastroenterology & Hepatology. Long-term efficacy and safety of dupilumab in patients with eosinophilic oesophagitis (LIBERTY EoE TREET ext)
In younger children aged 1 to 11, the results were similarly strong. About two-thirds of children on the higher-dose regimen achieved histologic remission, compared to only 3 percent on placebo, with significant improvements in endoscopic and molecular markers of disease.19PubMed. Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age Dupilumab is given as a subcutaneous injection, typically every week or every two weeks, and the most common side effects are injection-site reactions. For patients who cannot manage diet elimination or do not respond to topical steroids, it represents a genuinely different treatment mechanism.
Esophageal Dilation for Narrowing
When the esophagus has already narrowed from scarring and fibrosis, medications and diet can address the underlying inflammation but may not immediately fix the structural problem. Esophageal dilation, in which a doctor stretches the narrowed area during an endoscopy using a balloon or graduated dilators, provides direct mechanical relief. In a study of over 100 patients, 87 percent reported symptom improvement after dilation, with the average esophageal diameter increasing from about 12.5 mm to 15.2 mm between first and last procedures.20PubMed Central. Outcomes of esophageal dilation in eosinophilic esophagitis: Safety, efficacy, and persistence of the fibrostenotic phenotype
There was a period when dilation in EoE patients was viewed cautiously because of concerns about tearing the fragile esophageal tissue. While small superficial tears do occur, the procedure is now considered safe and effective in experienced hands. Newer techniques, including specialized endoscopic attachment caps, have produced similarly strong results, with one study showing symptom severity scores dropping from 32 to essentially zero within two weeks of dilation.21PubMed. Technical feasibility, clinical effectiveness, and safety of esophageal stricture dilation using a novel endoscopic attachment cap in adults with eosinophilic esophagitis Dilation treats the structural consequences of EoE but does not address the underlying inflammation, so it is typically used alongside medical or dietary therapy rather than as a standalone approach.
EoE Progresses if Left Untreated
This is one of the most important things to understand about EoE: it is not static. Left untreated, it tends to move from a primarily inflammatory state toward a scarring, narrowing state over time. A phenotypic analysis of EoE patients found that for every 10-year increase in age, the odds of having a fibrostenotic (scarring) form of the disease more than doubled.22PubMed Central. A phenotypic analysis shows eosinophilic esophagitis is a progressive fibrostenotic disease Younger patients were more likely to have the inflammatory type, with symptoms like vomiting and abdominal pain, while older patients were more likely to present with dysphagia, food impaction, and measurable esophageal narrowing.
This progression is not inevitable for every patient, and effective treatment can slow or halt fibrosis. But the data make a strong case against a wait-and-see approach. The longer inflammation goes unchecked, the more structural damage accumulates, and structural damage is harder to reverse than active inflammation.
Genetics and the Connection to Other Allergic Conditions
EoE does not appear randomly. It clusters in families and is strongly associated with other allergic conditions like asthma, eczema, hay fever, and food allergies. Genetic studies have identified variants in several genes that help explain this overlap. Some of the identified variants, in genes like FLG, DSG1, and CAPN14, relate to the structural integrity of the esophageal barrier, while others, in genes like CCL26 and TSLP, connect to the type-2 immune pathways shared across allergic diseases.23PubMed Central. Role of genetics, environment, and their interactions in the pathogenesis of eosinophilic esophagitis
One study found that children carrying risk variants in two key genes simultaneously had nearly four times the odds of developing EoE compared to those without the variants, demonstrating that the genetic susceptibility involves interactions between multiple genes rather than a single culprit.24PubMed Central. Eosinophilic esophagitis genetic susceptibility is mediated by synergistic interactions between EoE-specific and general atopic disease loci Environmental factors also seem to play a role. Research has explored whether early-life exposures like antibiotic use, cesarean delivery, and changes in the microbiome contribute to EoE development, though making causal claims remains difficult because of the long diagnostic delays typical of this disease.
Living with EoE and Its Emotional Weight
The clinical trials and eosinophil counts tell only part of the story. People living with EoE deal with a condition that touches virtually every meal, every social gathering, and every restaurant visit. Surveys have found that patients and caregivers report a sense of mourning after diagnosis, related to the impact on diet, eating habits, and social activities. About a third of patients report high impact on emotional health and social life, and most healthcare providers say their EoE patients experience anxiety or depression at some point during the year.25Asthma and Allergy Foundation of America. Life with Eosinophilic Esophagitis
Elimination diets, while effective, carry their own emotional burden. The difficulty of eating away from home, trusting food prepared by others, and maintaining restrictive diets over months or years takes a real psychological toll.26PubMed Central. Emotional Journey of Patients with Eosinophilic Esophagitis Children with EoE may feel isolated at school lunches and birthday parties. Adults may dread work dinners or dates. The fear of a food impaction episode, which can be painful and frightening, adds a layer of anxiety around eating that people without the condition rarely appreciate.
Monitoring Without Repeated Endoscopies
One of the practical frustrations of EoE is that tracking the disease requires looking at tissue under a microscope. You cannot tell from symptoms alone whether the inflammation is under control, since symptoms and eosinophil counts do not always move together. This means that any change in treatment, any food reintroduction, and any check on disease status has traditionally required another endoscopy with biopsies. For children especially, each procedure means another round of sedation.
Researchers have been working on less invasive alternatives. The esophageal string test, in which a patient swallows a capsule attached to a thin string that absorbs proteins from the esophageal surface during a one-hour wear period, has shown it can accurately distinguish active from inactive disease in both children and adults.27PubMed Central. One-Hour Esophageal String Test: A Nonendoscopic Minimally Invasive Test That Accurately Detects Disease Activity in Eosinophilic Esophagitis A systematic review of emerging noninvasive approaches, including blood and urine biomarkers along with advanced imaging techniques, found that several of these methods showed sensitivity and specificity comparable to biopsy for detecting disease.28PubMed Central. Advances in diagnostic techniques for eosinophilic esophagitis: a systematic review of emerging noninvasive methods None has replaced endoscopy as the gold standard yet, but the direction is clearly toward reducing the procedural burden, particularly for patients who need frequent monitoring during dietary reintroduction phases.
Growing Up with EoE
Because EoE is chronic and often diagnosed in childhood, a large number of patients face the challenge of transitioning from pediatric to adult healthcare. This shift involves more than finding a new doctor. A survey of patients who went through the transition found that the biggest struggles were practical: meal planning, grocery shopping, finding safe foods, and understanding insurance coverage. Perhaps most telling, while most respondents said they felt knowledgeable enough to manage their condition, nearly half still worried about managing it going forward.29PubMed. Transition of Care from Pediatric to Adult Care in Eosinophilic Esophagitis: Insights From a Patient Perspective Survey
The transition period matters clinically because losing continuity of care can mean missed monitoring, interrupted treatments, and a window where fibrosis progresses unchecked.30PubMed Central. Bridging eosinophilic esophagitis: healthcare transition from pediatric to adult patients In pediatric gastroenterology, parents often coordinate care and advocate for the child. When a young adult suddenly has to manage endoscopy scheduling, medication refills, dietary planning, and insurance paperwork independently, gaps open up. Structured transition programs are increasingly recognized as important, though they are still far from universal.